ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Evinacumab shows promise in severe hypertriglyceridemia trial europeanpharmaceuticalreview
May 18, 2021The investigational antibody evinacumab was able to lower triglycerides by up to 82 percent in severe hypertriglyceridemia patients with acute pancreatitis. -
FDA Approves Evkeeza americanpharmaceuticalreview
February 22, 2021Regeneron Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approved EvkeezaTM (evinacumab-dgnb) as an adjunct to other low-density lipoprotein cholesterol (LDL-C) lowering therapies to treat adult and pediatric patients aged 12 ...
Pharma Sources Insight January 2025
